RxDoctor Payments Data

Alejandro Casanova Vergaray

Acute Care · Kearney, NENPI 1407636053

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $486 of the $547 with a category attached, or 88.9%. 7 manufacturers reported payments, led by AbbVie at 30.2% of the total.

$547in general payments, 2019–2025

Across 28 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$165
  • Johnson & Johnson$144
  • Lilly USA, LLC$92
  • Takeda Pharmaceuticals U.S.A., Inc.$72
  • Pfizer$36
  • Sanofi$21
  • plus $18 from 1 others

What the payments were for

  • Food & beverage$48689%
  • Education$6111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 60th percentile of 103 acute care providers in Nebraska.

See all acute care providers in Nebraska

Medicare billing

Part B allowed, 2024
$2,213
Medicare patients
23
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Kearney

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →